Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-17-007110
Filing Date
2017-11-16
Accepted
2017-11-16 16:56:14
Documents
1
Period of Report
2017-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 formfour.html 4  
1 FORM 4 formfour.xml 4 3713
  Complete submission text file 0001171843-17-007110.txt   5057
Mailing Address C/O SUPERGEN, INC. 4140 DUBLIN BLVD., SUITE 200 DUBLIN CA 94568
Business Address
AZAB MOHAMMAD (Reporting) CIK: 0001309653 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 171208589

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations